Content area

|
|

Effectiveness of propanolol for treatment of infantile haemangioma

Forfatter(e)
Ida Gillberg Andersen¹, Catherine Rechnitzer² & Birgitte Charabi³ 1) Faculty of Health and Medical Sciences, University of Copenhagen 2) Department of Paediatrics and Adolescent Medicine, Rigshospitalet 3) Department of Otorhinolaryngology, Head and Neck Surgery, Rigshospitalet
INTRODUCTION Infantile haemangiomas (IH) are the most common benign tumours in children. They are characterised by rapid growth during the first year of life followed by spontaneous regression during childhood. Indications for treatment are functional impairment, bleeding/ulceration, rapid growth and severe aesthetic risk. Recently, systemic treatment with propranolol has become the first-line therapy. The objective of this study was to assess the efficacy of propranolol in the treatment of IH and to investigate whether treatment with a low dose of 1 mg/kg/day was sufficient. MATERIAL AND...
Blad nummer: 
Sidetal: 
247
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frederik Winsløw | 22/10
2 kommentarer
af Jens Meyer Svendsen | 21/10
2 kommentarer
af Sven Refslund Poulsen | 16/10
1 Kommentar
af Jens Ole Mathiesen | 16/10
1 Kommentar
af Gunnar Lauge Nielsen | 13/10
1 Kommentar
af Morten Krogh Jensen | 13/10
11 kommentarer
af Frank Østergaard Hansen | 12/10
1 Kommentar